Mergers & Acquisitions ·
Jin Medical International Ltd. entered into a VIE Control Acquisition and Share Issuance Agreement on June 29, 2026…
ZJYLJin Medical International Ltd.
Jin Medical International Ltd. entered into a VIE Control Acquisition and Share Issuance Agreement on June 29, 2026, to acquire contractual control over Beijing Tongsheng Technology Co., Ltd. through VIE arrangements. The company expects to issue approximately 64,186,456 Class A Ordinary Shares to the seller, with an additional 6,418,646 Class A Ordinary Shares to be issued to Goldeenridge Ventures Ltd. as advisory fees. The transaction is subject to shareholder approval at an upcoming extraordinary general meeting and is anticipated to occur in July 2026. Jin Medical International Ltd. is a medical technology company operating in the healthcare sector.